With the OHIP Plus finally kicking in, I wonder if there have been any unintended consequences that we are just starting to realize. Many have argued it is a political move from the Liberal party to secure a “sure win” in the upcoming election. Others may see it as a step toward a Universal Pharmacare in Canada. One way or another, its intention is to allow all children and youth under the age of 25 in Ontario to have access to prescription medications without any barriers.
The American Psychiatry Association has just released new practice guidelines for the pharmacological treatment of patients with alcohol use disorder. For the full guidelines, click here. In this guideline, the use of these 5 agents have been discussed: naltrexone, acamprosate, disulfiram, topiramate and gabapentin.
I have ranted about drug shortages in the past. It is extremely frustrating that medications go on drug shortage with little warning, or when drug shortages occur, simple modification of the therapy isn’t an option.
Happy New Year! As we begin the year of 2018, there are few things that I want to work on professionally. But the main mission is to focus on delivering values beyond the script.
As 2017 comes to an end, I want to reflect on some of the highlights for my blog.
First, here are my top 10 most commonly viewed posts or pages:
I recently broke my prescription glasses and was forced to purchase a new frame from a local eyeglasses provider. At the same time, I also had to visit my pharmacy to refill a prescription for my daughter. The striking difference in my experience has inspired me to write this post. Continue reading Patient Experience Matters
If you live in Ontario, OHIP Plus will be effective as of Jan 1, 2018 which means the Ontario Drug Benefits Program will pay for a number of prescription medications for anyone below the age of 25. So what do you really need to know?